MSB 1.49% $1.02 mesoblast limited

Ann: Update on Novartis Agreement, page-655

  1. 11,436 Posts.
    lightbulb Created with Sketch. 508
    Fantastic buying opportunity as gold standard random controlled trials prove the tech works and likely to need more increased dosing to broaden success over full spectrum of patients that are presenting for trials with no adverse health effects reported!

    Very rare!

    Not advice to anyone do your own research but I will be averaging down most definitely!

    With intent to live larger in retirement than previously intended!!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.